Prevalence of Vitamin D Deficiency in Healthy Adults

Yıl 2019, Cilt: 13 Sayı: 3, 335 - 341, 20.09.2019

Esra Paydaş Hataysal , Beyza Saraçlıgil Sedat Abuşoğlu Ali Ünlü , Hüsamettin Vatansev

https://doi.org/10.21763/tjfmpc.451729

Cited By: 1

Öz

Objectives: Vitamin D is a
well-known hormone and important for many metabolic pathways and different
health outcomes. The physiology of vitamin D is very complex. Multiple factors
like ethnicity, age, sex, diseases, and medication influence vitamin D
concentrations. In this study, our aim was to determine the prevalence
of vitamin D deficiency among adults in 
Turkey.
Material-methods: The 25(OH) vitD₃
test results of 2007 patients admitted to Selçuk University Medicine Faculty hospital
between the years of 2015 and 2016 were analyzed, retrospectively. Patients
using any vitamin D consisting drug, having chronic disease and inflammatory
disorders were excluded. Vitamin D levels were measured by a
chromatographic method (LC/MS/MS) with API3200 which is the gold standard to
measure 25(OH)D₃. Results: Our
results show that the prevalence of vitamin D deficiency is
about 67.9%  in our society. The mean
value of vitamin D was 16,87 ng/mL and females had significantly lower 25(OH)D₃
levels compared to males (p<0.001).The 25(OH)D₃ levels were
higher in summer and in fall than in winter and spring. (p<0.001) Conclusıons: The results indicate that
vitamin D deficiency is prevalent in this study population despite high
levels of sunshine and UV radiation throughout the year. Preventive treatments should be
planned.

Amaç: D vitamini,
birçok metabolik yolakta rol alan ve bazı hastalıklarla ilişkili olan bir
hormondur. Vitamin D fizyolojisi çok karmaşıktır.  Etnik köken, yaş, cinsiyet, hastalıklar ve
ilaç kullanımı vitamin D konsantrasyonunu etkilemektedir. Bu çalışmada amacımız
Türkiye’de sağlıklı erişkinlerde vitamin D eksikliği sıklığını belirlemekti. Yöntem: 2015-2016
yılları arasında Selçuk Üniversitesi Tıp Fakültesi Hastanesi'ne başvuran 2007
hastanın 25(OH)D₃ test sonuçları retrospektif olarak incelendi. Vitamin
D içeren ilaç kullanan, kronik hastalık veya enflamatuar hastalıkları olan
hastalar çalışma dışı bırakılmıştır. D vitamini seviyeleri, 25(OH)D₃
ölçmek için altın standart olan kromatografik yöntemle (LC / MS / MS) API3200
cihazı ile ölçülmüştür. Sonuçlar: Bulgularımız,
çalışma popülasyonumuzda D vitamini eksikliği prevalansının yaklaşık %67,9
olduğunu göstermektedir. D vitamini ortalama değeri 16,87 ng/mL idi ve
kadınlarda 25(OH)D3 seviyeleri, erkeklere göre anlamlı derecede düşüktü (p
<0,001). Yaz ve sonbahar mevsiminde 25 (OH) D3 seviyeleri, kış ve ilkbahar
mevsimine göre daha yüksekti.(p <0.001) Tartışma: Sonuçlarımız
yıl boyunca yüksek düzeyde güneş ve UV ışığına rağmen, D vitamini eksikliğinin
popülasyonumuzda yaygın olduğunu göstermektedir. Önleyici tedaviler
planlanmalıdır.

Anahtar Kelimeler

Vitamin D deficiency, LC/MS/MS, prevalence

Kaynakça

• 1. Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003;22:142-146.
• 2. Wacker M, Holick MF. Sunlight and vitamin D: a global perspective for health. Dermato-Endocrinol. 2013;5(1):51–108.
• 3. Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord (2017) 18:153–165 DOI 10.1007/s11154-017-9424-1
• 4. Altieri B, Muscogiuri G, Barrea L, Mathieu C, Vallone CV, Mascitelli L et al. Rev Endocr Metab Disord. Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept. (2017) Sep;18(3):335-346. doi: 10.1007/s11154-016-9405-9.
• 5. Battault S, Whiting SJ, Peltier SL, Sadrin S, Gerber G, Maixent JM. Vitamin D metabolism, functions, and needs: from science to health claims. Eur J Nutr (2013) 52:429–441 DOI 10.1007/s00394-012-0430-5
• 6. Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol. 2014 October; 144PA: 138–145. doi:10.1016/j.jsbmb.2013.11.003
• 7. Daly RM, Gagnon C, Lu ZX, et al. Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin Endocrinol. 2012; 77:26–35.
• 8. Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev 2012; 12:127-36; PMID:22776787; http://dx.doi.org/10.1016/j.autrev.2012.07.007
• 9. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266–81.
• 10. Granlund L, Ramnemark A, Andersson C et al. Prevalence of vitamin D deficiency and its association with nutrition, travelling and clothing habits in an immigrant population in Northern Sweden. European Journal of Clinical Nutrition (2016) 70, 373–37
• 11. Holick MF, Siris ES, Binkley N, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005; 90:3215–24.
• 12. Binkley N, Krueger D, Cowgill CS et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 2004; 89:3152–7.
• 13. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences- Am J Clin Nutr. 2008 Apr;87(4):1080S-6S
• 14. Pearce SH, Cheetham TD. Diagnosis and management of vitamin D deficiency. BMJ 2010; 340: b5664.
• 15. Rosen CJ, Gallagher JC. The 2011 IOM report on vitamin D and calcium requirements for North America: clinical implications for providers treating patients with low bone mineral density. J Clin Densitom 2011; 14: 79–84.
• 16. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53-58
• 17. Tang JCY, Nicholls H, Piec I, Washbourne CJ, Dutton JJ.et all. Reference intervals for serum 24,25-dihydroxyvitamin D and the ratio with 25-hydroxyvitamin D established using a newly developed LC–MS/MS method, Journal of Nutritional Biochemistry 46 (2017) 21–29. 18. Institute of Medicine 2011 Dietary reference intakes for calcium and vitamin D. Washington, DC: The National Academies Press.
• 19. Çidem M, Karacan İ, Beytemur O et al. Prevalence and risk factors for vitamin D deficiency in patients with widespread musculoskeletal pain. Turk J Med Sci (2017) 47: 728-731/ doi:10.3906/sag-1508-30
• 20. Durmuş H, Çetinkaya F. Vitamin D Status of Adults in Kayseri, Turkey: Summer Time Population Based Cross-Sectional Study. J Clin Anal Med 2017;8(suppl 4): 325-9.
• 21. Hekimsoy Z, Dinç G, Kafesçiler S, Onur E, Güvenç Y, Pala T et al. Vitamin D status among adults in the Aegean region of Turkey. BMC Public Health 2010;10(1):782
• 22. Alagöl F, Shihadeh Y, Boztepe H, Tanakol R, Yarman S, Azizlerli H et al. Sunlight exposure and vitamin D deficiency in Turkish women. Journal of Endocrinological Investigation 2000;23(3):173-7
• 23. Haq A, Svobodová J, Imran S, Stanford C, Razzaque MS. Vitamin D deficiency: A single centre analysis of patients from 136 countries. The Journal of steroid biochemistry and molecular biology 2016;164(9):209-13
• 24. Al-Hilali K. Prevalence of Hypovitaminosis D in Adult Iraqi People Including Postmenopausal Women. Scientific Research Journal (SCIRJ), Volume IV, Issue IX, September 2016, ISSN 2201-2796.
• 25. Hovsepian S, Amini M, Aminorroaya A, Amini P, Iraj B. Prevalence of Vitamin D Deficiency among Adult Population of Isfahan City, Iran. . J Health Popul Nutr (2011) Apr;29(2):149-155 ISSN 1606-0997.
• 26. Van der Wielen RP, Löwik MR, van den Berg H, de Groot LC, Haller J, Moreiras O, van Staveren WA: Serum vitamin D concentrations among elderly people in Europe. Lancet 1995, 346:207-2l0.
• 27. Lips P. Vitamin D status and nutrition in Europe and Asia. The Journal of Steroid Biochemistry and Molecular Biology 2007;103(3):620-5.